Company Profile Company Milestones Executive Management Financial Highlights Corporate Governance Virtual Press Kit SER Statement
Integrated Services Manufacturing & Distribution Service Milestones Supply Chain Sustaining Services Technology & Design Working With Jabil
Market Overview Automotive Computing & Storage Defense & Aerospace Digital Home & Office Instrumentation & Medical Mobility Networking Telecommunications Other
Investor Profile Corporate Governance Financials Events & Presentations Stock Data Investor Inquiry
News in Brief News Releases
Worldwide Locations
Executive Management

David M. Stout

Director

Mr. Stout has served as a director of Jabil since September 2009.

Mr. Stout was President, Pharmaceuticals, GlaxoSmithKline, with responsibility for global pharmaceutical operations, from January 2003 to February 2008.  Prior to that, he served as President, U.S. Pharmaceuticals from 1999 to January 2003.  He served as Senior Vice President and Director, Sales and Marketing-U.S., for SmithKline Beecham from October 1996 until 1998.  Mr. Stout was President of Schering Laboratories, a division of Schering-Plough Corporation, from 1994 until 1996.  He held various executive and sales and marketing positions with Schering-Plough from 1979, when he joined the company, until 1994.  

Currently, Mr. Stout serves as a director of Airgas Incorporated, NanoBio Corporation and Allos Therapeutics.

<< Back to Jabil Executive Management